About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cancer Genetics
›
Top Articles
Cancer Genetics
0.9
(top 50%)
impact factor
1.7K
(top 10%)
papers
14.4K
(top 20%)
citations
52
(top 10%)
h
-index
0.9
(top 50%)
impact factor
2.1K
all documents
15.4K
doc citations
81
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Genetics of adult glioma
Cancer Genetics
2012
737
2
Promiscuous partnerships in Ewing's sarcoma
Cancer Genetics
2011
213
3
The prognostic significance of cytogenetics and molecular profiling in multiple myeloma
Cancer Genetics
2011
178
4
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background
Cancer Genetics
2012
177
5
miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition
Cancer Genetics
2011
158
6
Regulatory mechanisms of long noncoding RNAs on gene expression in cancers
Cancer Genetics
2017
157
7
The genetics of dyskeratosis congenita
Cancer Genetics
2011
131
8
Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches
Cancer Genetics
2013
131
9
Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma
Cancer Genetics
2011
126
10
The cancer COMPASS: navigating the functions of MLL complexes in cancer
Cancer Genetics
2015
122
11
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
Cancer Genetics
2014
119
12
Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years
Cancer Genetics
2016
118
13
Translocation t(7;19)(q22;q13)—a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?
Cancer Genetics
2011
113
14
Molecular inversion probes: a novel microarray technology and its application in cancer research
Cancer Genetics
2012
103
15
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia
Cancer Genetics
2015
102
16
Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets
Cancer Genetics
2013
99
17
Clinical application of amplicon-based next-generation sequencing in cancer
Cancer Genetics
2013
98
18
Evaluation of commercial kits for purification of circulating free DNA
Cancer Genetics
2018
90
19
Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints
Cancer Genetics
2012
86
20
MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells
Cancer Genetics
2012
85
21
Exon scanning by reverse transcriptase–polymerase chain reaction for detection of known and novel EML4–ALK fusion variants in non–small cell lung cancer
Cancer Genetics
2011
84
22
Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells
Cancer Genetics
2015
84
23
Bone morphogenetic protein 4—a fascinating regulator of cancer cell behavior
Cancer Genetics
2012
81
24
Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma
Cancer Genetics
2013
81
25
Pathology and diagnosis of SMARCB1-deficient tumors
Cancer Genetics
2014
81
26
Clinical genomics of renal epithelial tumors
Cancer Genetics
2011
80
27
Molecular pathology and its diagnostic use in bone tumors
Cancer Genetics
2012
80
28
Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis
Cancer Genetics
2011
79
29
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity
Cancer Genetics
2011
77
30
5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy
Cancer Genetics
2015
77
31
The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma
Cancer Genetics
2016
77
32
The genetics of gestational trophoblastic disease: a rare complication of pregnancy
Cancer Genetics
2012
76
33
Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
Cancer Genetics
2014
76
34
MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
Cancer Genetics
2012
74
35
FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform
Cancer Genetics
2011
73
36
ARID1A and TERT promoter mutations in dedifferentiated meningioma
Cancer Genetics
2015
73
37
Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population
Cancer Genetics
2012
72
38
Germline and somatic mutations in meningiomas
Cancer Genetics
2015
72
39
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
Cancer Genetics
2014
71
40
Circulating cell-free DNA for non-invasive cancer management
Cancer Genetics
2018
71
41
A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations
Cancer Genetics
2012
70
42
MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm
Cancer Genetics
2013
69
43
Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort
Cancer Genetics
2016
68
44
Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories
Cancer Genetics
2017
68
45
The role of the histone demethylase KDM4A in cancer
Cancer Genetics
2015
66
46
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)
Cancer Genetics
2018
65
47
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease
Cancer Genetics
2013
63
48
Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines
Cancer Genetics
2015
63
49
MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma
Cancer Genetics
2012
60
50
Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes
Cancer Genetics
2011
59
site/software ©
exaly
; All materials licenced under
CC by-SA
.